Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder.
- R. Ellis, S. Letendre, +13 authors J. McCutchan
- Clinical infectious diseases : an official…
- 1 April 2014
BACKGROUND Antiretroviral (ARV) medications differentially penetrate across the blood-brain barrier into central nervous system (CNS) tissues, potentially influencing their effectiveness in treating… Expand
The Hepatitis C Cascade of Care among HIV Infected Patients: A Call to Address Ongoing Barriers to Care
Background The aims were to investigate the hepatitis C (HCV) cascade of care among HIV-infected patients and to identify reasons for not referring for and not initiating HCV therapy after completion… Expand
Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy.
The objectives of this research were to assess prevalence and predictors of early antiretroviral therapy adherence using multiple indicators and to estimate effects of early adherence on subsequent… Expand
Predictors of Missed Hepatitis C Intake Appointments and Failure to Establish Hepatitis C Care Among Patients Living With HIV
- E. Cachay, L. Hill, +4 authors W. Christopher Mathews
- Open forum infectious diseases
- 1 July 2018
Abstract Background We estimated and characterized the proportion of patients living with HIV (PLWH) who missed hepatitis C (HCV) intake appointments and subsequently failed to establish HCV care.… Expand
Increasing Hepatitis C treatment uptake among HIV-infected patients using an HIV primary care model
BackgroundAccess to Hepatitis C (HCV) care is low among HIV-infected individuals, highlighting the need for new models to deliver care for this population.MethodsRetrospective cohort analysis that… Expand
The Impact of Direct-Acting Antivirals in the Hepatitis C-Sustained Viral Response in Human Immunodeficiency Virus-Infected Patients With Ongoing Barriers to Care
Using an inclusive HCV treatment protocol that encourages prospective engagement in care, HIV-infected patients with and without ongoing barriers to care had similar chances of HCV sustained viral… Expand
Health beliefs and discontinuation of zidovudine therapy.
High incidence of serious adverse events in HIV-infected patients treated with a telaprevir-based hepatitis C virus treatment regimen
Objectives:To report the rates of grade IV adverse events and hepatitis C virus (HCV) treatment discontinuation associated with the use of telaprevir, pegylated interferon, and ribavirin.… Expand
Outcomes of pharmacist-assisted management of antiretroviral therapy in patients with HIV infection: A risk-adjusted analysis.
- O. N. Nevo, Catherine R. Lesko, B. Colwell, C. Ballard, S. Cole, W. C. Mathews
- American journal of health-system pharmacy : AJHP…
- 1 September 2015
PURPOSE The impact of pharmacist-assisted management (PAM) of pharmacotherapy for patients with human immunodeficiency virus (HIV) infection was investigated. METHODS A retrospective cohort… Expand